EAP and COVID-19: Brainspotting Proving Useful in Treating COVID-19 Trauma
JournalEmployee Assistance Report
PublisherWrite it Right LLC
MetadataShow full item record
Other TitlesBrainspotting Proving Useful in Treating COVID-19 Trauma
AbstractAs EAP providers, we work with clients with a multitude of presenting issues within a limited amount of time. In a single day, we might see clients experiencing anxiety, depression, PTSD, adjustment problems, relationship issues, etc. We each have our own go-to modalities and most of the time, we see at least some progress. But what if there were a modality that you could easily integrate into your practice that works with current techniques and could increase your clients’ progress substantially? For myself and over 13,000 other clinicians worldwide, that modality is Brainspotting – an approach that is also proving useful in assisting people suffering from COVID-19-related trauma. But before we get into how Brainspotting is helping individuals during this challenging time, it’s necessary to first understand what it is.
KeywordCoronavirus Disease 2019 (COVID-19)
Employee assistance programs
Eye Movement Desensitization Reprocessing
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/12941
Showing items related by title, author, creator and subject.
Immune Correlates of COVID-19 ControlPoonia, Bhawna; Kottilil, Shyam (Frontiers Media S.A., 2020-09-29)COVID-19 caused by SARS CoV2 emerged in China at the end of 2019 and soon become a pandemic. Since the virus is novel, pre-existing CoV2-specific immunity is not expected to exist in humans, although studies have shown presence of CoV2 cross-reactive T cells in unexposed individuals. Lack of effective immunity in most individuals along with high infectiousness of the virus has resulted in massive global public health emergency. Intense efforts are on to study viral pathogenesis and immune response to help guide prophylactic and therapeutic interventions as well as epidemiological assessments like transmission modeling. To develop an effective vaccine or biologic therapeutic, it is critical to understand the immune correlates of COVID-19 control. At the same time, whether immunity in recovered individuals is effective for preventing re-infection will be important for informing interventions like social distancing. Key questions that are being investigated regarding immune response in COVID-19 which will help these efforts include, investigations of immune response that distinguishes patients with severe versus mild infection or those that recover relative to those that succumb, durability of immunity in recovered patients and relevance of developed immunity in a cured patient for protection against re-infection as well as value of convalescent plasma from recovered patients as a potential therapeutic modality. This is a broad and rapidly evolving area and multiple reports on status of innate and adaptive immunity against SARS-CoV2 are emerging on a daily basis. While many questions remain unanswered for now, the purpose of this focused review is to summarize the current understanding regarding immune correlates of COVID-19 severity and resolution in order to assist researchers in the field to pursue new directions in prevention and control. © Copyright © 2020 Poonia and Kottilil.
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi methodNasa, Prashant; Azoulay, Elie; Khanna, Ashish K; Jain, Ravi; Gupta, Sachin; Javeri, Yash; Juneja, Deven; Rangappa, Pradeep; Sundararajan, Krishnaswamy; Alhazzani, Waleed; et al. (Springer Nature, 2021-03-16)Using a Delphi process, an international panel of 39 experts developed clinical practice statements on the respiratory management of C-ARF in areas where evidence is absent or limited. Agreement was defined as achieved when > 70% experts voted for a given option on the Likert scale statement or > 80% voted for a particular option in multiple-choice questions. Stability was assessed between the two concluding rounds for each statement, using the non-parametric Chi-square (χ2) test (p < 0·05 was considered as unstable).